C
CRISPR Therapeutics
CRSP · NASDAQ · Healthcare
$53.68
+$2.12 (+3.95%) today
Loading live data...
Market Cap
$5.19B
24h Volume
$50.8M
P/E Ratio
-8.5
52w High
$76.78
52w Low
$44.34
Est. AI Revenue
8%
Loading chart data...
7-Day Sparkline (Static)
About CRISPR Therapeutics
Gene-editing biotechnology company applying AI/ML to optimize CRISPR guide RNA design and therapeutic target identification.
CEO: Samarth Kulkarni
Founded: 2013
HQ: Zug, Switzerland
Employees: 1,200
Performance
24 Hours+3.95%
7 Days+11.86%
30 Days-4.72%
1 Year-4.07%